Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04501757
Title Naxitamab and GM-CSF in People With Neuroblastoma
Recruitment Approved for marketing
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center



Naxitamab + Sargramostim

Age Groups: child | adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from for the field